Starpharma Holdings
Starpharma Holdings is an Australian biotechnology company focused on developing dendrimer technology for pharmaceutical and life science applications. Their proprietary dendrimer platform is used to improve drug delivery, enhance drug efficacy, and create new pharmaceutical products. The company's market position is built on its innovative technology and partnerships with pharmaceutical companies.
Short position
Starpharma Holdings (ASX:SPL) has 0.03% of its shares on issue reported as short positions as of 5 Oct 2026, or about 150,000 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.08 percentage points. Its highest recorded short interest was 5.92% in September 2013. SPL is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Starpharma Holdings (SPL) company profile
Profile, insiders and operations
Company
AI-generated research profile of Starpharma Holdings
SPL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links